Don’t miss the latest developments in business and finance.

Parenteral Drugs (India) reports standalone net loss of Rs 10.70 crore in the September 2015 quarter

Image
Capital Market
Last Updated : Nov 10 2015 | 10:02 AM IST

Sales rise 23.66% to Rs 58.69 crore

Net Loss of Parenteral Drugs (India) reported to Rs 10.70 crore in the quarter ended September 2015 as against net loss of Rs 17.30 crore during the previous quarter ended September 2014. Sales rose 23.66% to Rs 58.69 crore in the quarter ended September 2015 as against Rs 47.46 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales58.6947.46 24 OPM %8.715.73 -PBDT-5.44-11.96 55 PBT-10.70-16.38 35 NP-10.70-17.30 38

Powered by Capital Market - Live News

Also Read

First Published: Nov 10 2015 | 9:15 AM IST

Next Story